A new compound for GERD/Acid reflux treatment. www.nanomeda.com

2. Do you want to go with this PPI Drugs?
Big Problem?
• PPI drugs proven to cause vitamin B12
deficiency
• Tuesday, December 17, 2013 by: PF Louis
Tags: PPI drugs, B12 deficiency, vitamin
supplements
No!
Wait!
We have an option for you.
100% safe and effective solution for
GERD/Acid Reflux

3. Big Problem
• According to a new study in the Journal of the
American Medical Association, proton pump
inhibitors (PPIs) and histamine 2 receptor
antagonists (H2RAs) suppress gastric acid
production, which can mean that the Vitamin B12 in
food is not properly absorbed into the body. Vitamin
B12 deficiency is linked to serious health
complications, such as anemia, nerve damage, and
dementia
• The most commonly used PPIs are
Prilosec, Prevacid, Nexium, Protonix, and Aciphex.
The most popular H2RAs include
Zantac, Pepcid, and Tagamet.

4. MegnaCur-Discovery
A newly discovered
Compound for
Acid Reflux/GERD

5. GERD/Acid Reflux

6. Market Size
• In recent years, GI prescriptions have remained
one of the world’s largest therapeutic markets,
with sales of more than $20 billion
• Given the large public need and the propensity for
high returns, the gastroenterology market is set to
expand. As an increasing pool of smaller
specialty pharmaceutical players recognize the
need and importance of developing innovative
treatments to restore normal function of the GI
system and improve patients’ quality of life, the
doors to improved GI health are opening, and
opportunity

7. Established
•
•
•
•
•
•
•
•
•
A newly discovered compound
Proof of concept
No generic cliff
Patent protection
Pilot scale production
Raw material qualification
Manufacturing and QC protocols
Machinery identified
Formulation

8. Product
•
•
•
•
•
Capsule
Tablet
Syrup
Soft drink
Chewing gum
Ready to Launch

9. Next
•
•
•
•
•
cGMP manufacturing
Preclinicals
NDA
Clinical trials
Market/Partners/Exit

10. Funds
•
•
•
•
$3million 1st round
3-5 years for exit and product launch
We provide patent protection
Direct investment on clinical trials

11. Contact To Join Us
Mewa Singh, PhD
mewasinghsandhu@hotmail.com
609-902-7128
www.nanomeda.com
www.nanosgroup.com
Opportunity for $20Billion Market

12. MegnaCur-A new compound
for
GERD/Acid Reflux